Other languages Pharma Mar, S.A.

Equities

PHM

ES0169501022

Market Closed - BME Other stock markets 09:05:26 26/04/2024 pm IST			5-day change	1st Jan Change
28.96 ^EUR	+0.49%		+10.37%	-29.50%

23/04	Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
29/02	Transcript : Pharma Mar, S.A., 2023 Earnings Call, Feb 29, 2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EN DIRECTO DESDE LOS MERCADOS: Iberdrola, Inditex, BBVA, Pharma Mar, Vocento, Acerinox, Air Liquide, Kering, Tesla, Heineken, ENI...	24/04
Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04
EN DIRECTO DESDE LOS MERCADOS: Naturgy, Viscofan, Endesa, Bankinter, Aena, BYD, TotalEnergies, Tesla, UBS, Salesforce, Nike...	22/04
IN DIRETTA DAI MERCATI: Generali, Viscofan, Telecom Italia, Iveco, Henkel, BYD, TotalEnergies, Tesla, UBS, Salesforce, Nike...	22/04
Pharma Mar, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
OPINIONES DE LOS ANALISTAS DEL DÍA : Adyen, Endesa, Viscofan, Iberdrola, Repsol, Pharma Mar, NH Hotel, Nemetschek, Société Générale...	09/02
Bolsa de Madrid: Caramba, ¡falló otra vez!	09/02
EN DIRECTO DESDE LOS MERCADOS: Pharma Mar, Repsol, Cie Automotive, Alphabet, UBS, Acciona, Richemont, Covestro, Apple...	19/12
Pharma Mar's Sylentis Meets Primary Endpoint for Dry Eye Disease Medication	19/12
Pharma Mar Partner Wins Marketing Approval for Lung Cancer Drug in Hong Kong	12/12
Pharma Mar Partner Wins Approval for Lung Cancer Drug in Macao	04/12
Pharma Mar's Partner Wins Commercialization Approval for Zepzelca in Peru	07/11
PharmaMar Gets $10 Million Milestone Payment from Janssen Under Yondelis Licensing Deal	06/11
EN DIRECTO DESDE LOS MERCADOS: Pharma Mar, Sacyr, LVMH, Iberdrola, Dufry, Berkshire Hathaway, Ryanair, Telecom Italia	06/11
Pharma Mar, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26
OPINIONES DE LOS ANALISTAS DEL DÍA : Amadeus, Sacyr, Nokia, Telefónica, Pharma Mar, Novo Nordisk, Rheinmetall, Prosegur, Almirall, Vodafone...	11/23/11
Pharma Mar, S.A. commences an Equity Buyback Plan, under the authorization approved on May 31, 2023.	06/23/06
Pharma Mar, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	27/23/27
PharmaMar Secures Taiwan Regulatory Approval for Lung Cancer Treatment	11/23/11
El optimismo monetario e Inditex llevan el Ibex-35 a máximos de mes y medio	07/23/07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Pharma Mar, S.A.

Equities

PHM

ES0169501022

Other languages

Filters